Free to Choose Medicine

Nearly six million Americans of all ages are living with Alzheimer’s disease, and more than 16 million Americans care for people living with Alzheimer’s and other dementias.

The FDA has unlimited power and control when it comes to the treatments and therapies terminally ill patients can access.

As the 2020 election creeps closer, candidates are focusing increasingly more on solving one of the most vexing problems Americans regularly encounter: the incredibly high cost of prescription drugs.

For Jaci Hermstad and many others suffering from debilitating diseases such as amyotrophic lateral sclerosis (ALS), time and treatment options are limited.

Heartland’s Donald Kendal, and Jim Lakely are joined by Isaac Orr in episode #189 of the In The Tank Podcast. Today’s episode features work from the Property & Environment Research Center, the American Enterprise Institute, the Reason Foundation, and The Heartland Institute.

According to its mission statement, the Food and Drug Administration (FDA) is responsible for “advancing public health” by providing oversight to the drug development process.

Free To Choose Medicine legislation has the potential to gather bipartisan support as a practical means to accelerate innovation and lower the costs of prescription drugs.

The Food and Drug Administration has created a monopoly on access to new drugs, but there’s a better way.

The Tomorrow’s Cures Today Foundation (TCTF) says FDA regulations deprive terminally ill patients and their family members of hope. In a video posted February 6, TCTF tells the story of…

When it comes to life-saving drugs, we need more than modest reform.